rs121908841
Variant summary
Our verdict is Pathogenic. Variant got 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_003722.5(TP63):c.1028G>A(p.Arg343Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,816 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R343W) has been classified as Pathogenic.
Frequency
Consequence
NM_003722.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TP63 | NM_003722.5 | c.1028G>A | p.Arg343Gln | missense_variant | Exon 8 of 14 | ENST00000264731.8 | NP_003713.3 | |
TP63 | NM_001114980.2 | c.746G>A | p.Arg249Gln | missense_variant | Exon 6 of 12 | ENST00000354600.10 | NP_001108452.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TP63 | ENST00000264731.8 | c.1028G>A | p.Arg343Gln | missense_variant | Exon 8 of 14 | 1 | NM_003722.5 | ENSP00000264731.3 | ||
TP63 | ENST00000354600.10 | c.746G>A | p.Arg249Gln | missense_variant | Exon 6 of 12 | 1 | NM_001114980.2 | ENSP00000346614.5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461816Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 727210
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
TP63-Related Spectrum Disorders Pathogenic:2
This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 343 of the TP63 protein (p.Arg343Gln). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with Rapp-Hodgkin syndrome and acro-dermo-ungual-lacrimal-tooth (ADULT) syndrome and ectrodactyly, ectodermal dysplasia, and cleft lip/palate (EEC) syndrome (PMID: 10839977, 12525544, 26882220, 27028492). This variant is also known as p.Arg304Gln. ClinVar contains an entry for this variant (Variation ID: 6534). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on TP63 protein function. This variant disrupts the p.Arg343 amino acid residue in TP63. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 10535733, 12525544, 19353588, 20180707, 21652629, 23355676, 24734328). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
- -
Ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3 Pathogenic:2
- -
- -
Inborn genetic diseases Pathogenic:1
- -
not provided Pathogenic:1
Reported previously in the heterozygous state, using alternate nomenclature (R304Q), in association with ectrodactyly-ectodermal dysplasia-clefting (EEC) syndrome (Ianakiev et al., 2000; van Bokhoven et al., 2001; Barrow et al., 2002; Dianzani et al., 2003; de Mollerat et al., 2003); Observed in a female who lacked ectrodactyly, thus diagnosed with Rapp-Hodgkin syndrome, and her daughter who reportedly had all of the cardinal features of EEC syndrome (Brueggemann et al., 2016); Published functional studies demonstrate that this variant abolishes p63 transcriptional activity at promoters of the KRT14, IRF6, and DSC3 genes, and impairs its intrinsic DNA binding ability (Russo et al., 2018); Not observed in large population cohorts (Lek et al., 2016); Also known as p.R304Q; This variant is associated with the following publications: (PMID: 10839977, 12161593, 14684701, 12525544, 27028492, 29130604, 32224865, 31682841, 17224651, 21652629, 29339502, 11462173, 26882220) -
Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome;C1785148:Rapp-Hodgkin syndrome;C1851878:Orofacial cleft 8;C1854442:Split hand-foot malformation 4;C1858562:Ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3;C1863204:ADULT syndrome;C1863753:Limb-mammary syndrome;C5830399:Premature ovarian failure 21 Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at